European equities traded in the US as American depositary receipts eased late Tuesday morning with the S&P Europe Select ADR Index down 0.1% to 1,903.66.
From continental Europe, the gainers were led by consumer goods company Unilever (UL) and software firm SAP (SAP), which climbed 8.6% and 4.8%, respectively. They were followed by pharmaceutical company Sanofi (SNY) and brewing company Anheuser-Busch InBev (BUD), which advanced 3.7% and 3%, respectively.
The decliners from continental Europe were led by telecommunications operator Nokia (NOK) and biopharmaceutical company DBV Technologies (DBVT), which dropped 6.3% and 5.1%, respectively. They were followed by medical device maker EDAP TMS (FOCL) and semiconductor company Sequans Communications (SQNS), which lost 3.3% and 3.1%, respectively.
The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which rose 9.6% and 7.9%, respectively. They were followed by pharmaceutical company GSK (GSK) and communications company WPP (WPP), which were up 6.5% and 6.4%, respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and lender Barclays (BCS), which fell 7.8% and 7.3%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and lender Lloyds Banking Group (LYG), which dropped 7% and 2.5%, respectively.